Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutions
Study Details
Study Description
Brief Summary
Tolerability is compared between two Multi-purpose disinfecting solutions (MPDS).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
According to recent surveys of contact lens fitters, the most prescribed treatments for contact lens dryness are: more frequent replacement schedule (24%), refit into different material (23%), rewetting drops (21%) and change care system (15%). Changing care systems has been a standard treatment for CL discomfort for many years. In the same survey, 30% of practitioners felt there is absolutely no difference among solutions with respect to reducing dryness and discomfort.
The investigators set out to compare the clinical performance of these two solutions: AMO's RevitaLens and Alcon's Opti-Free PureMoist.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: RevitaLens AMO's RevitaLens contact lens solution |
Other: RevitaLens
Multi-purpose disinfecting solution
Other Names:
Other: OptiFree PureMoist
Multi-purpose disinfecting solution
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Self-reported comfort scores with contact lens care systems [14 days]
Comfort measured by questionnaires covering positive and negative attributes of contact lens wear
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Between the ages of 18 and over inclusive.
-
Males or females
-
Patient is in generally good & stable overall health.
-
Patient likely to comply with study guidelines & study visits.
-
Informed consent signed.
-
Are willing/able to return for all required study visits.
-
Are willing/able to follow instructions from the study investigator and his/her staff.
-
Have signed informed consent approved by Institutional Review Board or Independent Ethics Committee.
Exclusion Criteria:
-
Corneal refractive surgery within 6 months of this study.
-
Intra-ocular surgery within 6 months or ocular laser surgery within 6 months.
-
Ocular pathology (includes glaucoma and cataract), which could impact results and/or place patient at risk.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Milton M. Hom, OD, FAAO | Azusa | California | United States | 91702 |
2 | Kirk L. Smick, OD, FAAO. | Morrow | Georgia | United States | 30260 |
3 | Ian Ben Gaddie, OD, FAAO. | Louisville | Kentucky | United States | 40222 |
Sponsors and Collaborators
- Hom, Milton M., OD, FAAO
- Abbott Medical Optics
Investigators
- Principal Investigator: Milton M Hom, OD FAAO,
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 12-GHS Comfort Study